FDA Adverse Event Injury Summary report: N

G7 DUAL MOBILITY LINER 38MM C

MDR report key: 17306005 · Received July 12, 2023

Report

Report Number
0001825034-2023-01534
Event Type
Injury
Date Received
July 12, 2023
Date of Event
June 28, 2020
Report Date
July 7, 2023
Manufacturer
ZIMMER BIOMET, INC.
Product Code
LPH
PMA / PMN Number
K150522
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4). D10: EP-200144 ACT ARTIC E1 HIP BRG 28X38MM LOT NUMBER IS UNKNOWN. 650-1159 DELTA CER FEM HD 28/-3MM T1 LOT UNKNOWN. 51-103090 TPRLC 133 TYPE1 PPS SO 9X137MM LOT NUMBER UNKNOWN. G2: FOREIGN: SOUTH KOREA. NO PRODUCT WAS RETURNED OR PICTURES PROVIDED; VISUAL AND DIMENSIONAL EVALUATIONS COULD NOT BE PERFORMED. LOT IDENTIFICATION IS NECESSARY FOR REVIEW OF DEVICE HISTORY RECORDS, LOT IDENTIFICATION WAS NOT PROVIDED. MEDICAL RECORDS WERE PROVIDED AND REVIEWED BY A HEALTH CARE PROFESSIONAL. REVIEW OF THE AVAILABLE RECORDS IDENTIFIED THE FOLLOWING: AN INITIAL RIGHT THA WAS PERFORMED WITH NO COMPLICATIONS NOTED. THE PATIENT EXPERIENCED A DISLOCATION AND UNDERWENT A REVISION SURGERY. THE HEAD WAS EXCHANGED BUT IT'S UNKNOWN IF THE LINER OR BEARING WAS EXCHANGED. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS 0001825034-2023-01535. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT UNDERWENT A REVISION PROCEDURE 6 DAYS POST IMPLANTATION DUE TO DISLOCATION. THERE IS NO ADDITIONAL INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
249733 G7 DUAL MOBILITY LINER 38MM C PROSTHETIC, HIP LPH ZIMMER BIOMET, INC. N/A NI

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention| H